Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

LLM 2021 | Differentiating immune thrombocytopenia from IPD and PID

Michele Lambert • 11 Oct 2021
LLM 2021
General

Michele Lambert, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA, discusses the significance of differentiating pediatric immune thrombocytopenia (ITP) from primary immune deficiency (PID) and other thrombocytopenic disorders, including inherited platelet disorders (IPD). Evaluating patients with autoimmune diseases requires additional tests for underlying diseases and in the case of pediatric patients with ITP, it is necessary to check for a history of rheumatologic disease and other autoimmune diseases. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.

Disclosures

Advisory board member for Octapharma, Dova, Principia, Argenx and Shionogi
Consultant for Novartis, Shionogi, Dova, Principia, Argenx, Rigel and Bayer
Research funding from Sysmex, Novartis, Rigel, Principia, Argenx, Dova, Octapharma and Astra Zeneca

More from Michele Lambert

1:36
Inherited and acquired thrombocytopathies
Michele Lambert • 11 Oct 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals